Latest Insider Transactions at Processa Pharmaceuticals, Inc. (PCSA)
This section provides a real-time view of insider transactions for Processa Pharmaceuticals, Inc. (PCSA). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Processa Pharmaceuticals, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Processa Pharmaceuticals, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Aug 05
2021
|
Patrick Lin Chief Business - Strategy Off |
BUY
Grant, award, or other acquisition
|
Direct |
7,601
+1.78%
|
-
|
|
Aug 05
2021
|
James H Stanker Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
7,601
+14.7%
|
-
|
|
Aug 05
2021
|
Sian Bigora Chief Development Officer |
BUY
Grant, award, or other acquisition
|
Direct |
7,601
+1.89%
|
-
|
|
Aug 05
2021
|
Wendy Guy Chief Administrative Officer |
BUY
Grant, award, or other acquisition
|
Direct |
7,601
+3.96%
|
-
|
|
Aug 05
2021
|
Justin W Yorke |
BUY
Grant, award, or other acquisition
|
Direct |
1,169
+0.39%
|
-
|
|
Aug 05
2021
|
Geraldine Pannu |
BUY
Grant, award, or other acquisition
|
Direct |
1,169
+17.0%
|
-
|
|
Jun 23
2021
|
David Young Pres. Research & Development |
BUY
Open market or private purchase
|
Direct |
10,000
+2.82%
|
$70,000
$7.67 P/Share
|
|
Jun 22
2021
|
Robert Michael Floyd Chief Operating Officer |
BUY
Open market or private purchase
|
Direct |
2,000
+6.67%
|
$14,000
$7.03 P/Share
|
|
Jun 21
2021
|
James H Stanker Chief Financial Officer |
BUY
Open market or private purchase
|
Direct |
1,000
+2.67%
|
$6,000
$6.81 P/Share
|
|
Jun 21
2021
|
Patrick Lin Chief Business - Strategy Off |
BUY
Open market or private purchase
|
Direct |
2,000
+0.5%
|
$12,000
$6.65 P/Share
|
|
Apr 14
2021
|
Justin W Yorke |
SELL
Open market or private sale
|
Indirect |
9,700
-3.76%
|
$87,300
$9.42 P/Share
|
|
Apr 13
2021
|
Justin W Yorke |
SELL
Open market or private sale
|
Indirect |
6,500
-2.46%
|
$58,500
$9.86 P/Share
|
|
Apr 08
2021
|
James E Besser |
SELL
Open market or private sale
|
Direct |
400,000
-38.16%
|
$4,000,000
$10.76 P/Share
|
|
Apr 07
2021
|
James E Besser |
SELL
Open market or private sale
|
Direct |
16,000
-1.5%
|
$160,000
$10.67 P/Share
|
|
Apr 06
2021
|
James E Besser |
SELL
Open market or private sale
|
Direct |
31,771
-2.9%
|
$317,710
$10.91 P/Share
|
|
Feb 22
2021
|
James E Besser |
SELL
Open market or private sale
|
Direct |
20,929
-1.87%
|
$230,219
$11.56 P/Share
|
|
Feb 19
2021
|
James E Besser |
SELL
Open market or private sale
|
Direct |
3,000
-0.27%
|
$33,000
$11.2 P/Share
|
|
Feb 18
2021
|
James E Besser |
SELL
Open market or private sale
|
Direct |
5,000
-0.44%
|
$55,000
$11.35 P/Share
|
|
Oct 02
2020
|
James E Besser |
BUY
Open market or private purchase
|
Direct |
30,000
+6.9%
|
$120,000
$4.04 P/Share
|
|
Oct 01
2020
|
Patrick Lin Chief Business - Strategy Off |
BUY
Open market or private purchase
|
Direct |
31,250
+7.25%
|
$62,500
$2.1 P/Share
|
|
Oct 01
2020
|
James H Stanker Chief Financial Officer |
BUY
Open market or private purchase
|
Direct |
6,000
+11.27%
|
$12,000
$2.1 P/Share
|